Exome Asset Management
Overview
We invest in global healthcare companies
Investment Focus
- Rigorous fundamental research
- Long-biased returns with market-neutral risks
- Capitalizing on geographic value dislocations
Portfolio Companies
Reach Exome Asset Management directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Exome Asset Management
What sectors does Exome Asset Management invest in?
Exome Asset Management invests in Healthcare Services, Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Medical Equipment, and is based in New York, United States. Exome Asset Management is listed as a government in the ConnectSafely investor database.
What stage does Exome Asset Management invest at?
Exome Asset Management backs companies at Early Stage, Growth, Late Stage and Pre-IPO, writing cheques of $0 - $100K.
Which regions does Exome Asset Management invest in?
Exome Asset Management invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
Who are the partners at Exome Asset Management?
Team members listed for Exome Asset Management include Joseph Narvaez (Chief Operating Officer) and Sam Isaly (Managing Partner).
What companies has Exome Asset Management invested in?
Exome Asset Management's portfolio includes Aprea Therapeutics, Gracell Biotechnologies, Centrexion Therapeutics, IMPACT Therapeutics, Broncus Holding Corporation and NextCure.
How do I contact Exome Asset Management?
Exome Asset Management's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
